Full Text View
Tabular View
No Study Results Posted
Related Studies
Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert
This study is currently recruiting participants.
Verified April 2013 by CSL Behring
Study NCT01467947   Information provided by CSL Behring

First Received on November 7, 2011.   Last Updated on May 1, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Angioedema
Angioedemas, Hereditary
Hereditary Angioedema Types I and II
More general conditions related to this trial
Cardiovascular Diseases
Genetic Diseases, Inborn
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Skin Diseases
Skin Diseases, Vascular
Urticaria
Vascular Diseases
Additional drug interventions recognized in this trial
Complement C1 Inhibitor Protein
More general drug interventions related to this trial
Complement Inactivating Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
CSL Behring


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services